Item 9.01 Financial Statements and Exhibits. for CVS_Caremark

Send us Feedback

CVS Caremark Corporation (CVS)

	SUMMARY

	BULLS

	BEARS

	TOPICS

	DATA CENTRAL

	STOCK CHART

	SEC FILINGS

	BALANCE

	INCOME

	CASH FLOW

CVS » Topics » Item 9.01 Financial Statements and Exhibits.

This excerpt taken from the CVS 8-K filed May 5, 2009.

Item 9.01 Financial Statements and Exhibits.

(d)

Exhibits

99.1

Press Release, dated May 5, 2009, of CVS Caremark Corporation.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CVS CAREMARK CORPORATION

By: /s/ David B. Rickard

David B. Rickard

Executive Vice President,

Chief Financial Officer and

Chief Administrative Officer

Dated: May 5, 2009

This excerpt taken from the CVS 8-K filed Jan 23, 2009.

Section 9—Financial Statements and Exhibits

Item 9.01

Financial Statements and Exhibits

(d)

Exhibits


Exhibit No.		Document
3.2		Amended and Restated By-laws of CVS Caremark Corporation

This excerpt taken from the CVS 8-K filed Feb 6, 2008.

Section 9 - Financial Statements and Exhibits

Item 9.01

Financial Statements and Exhibits

(d)

Exhibits


Exhibit No.		Document
3.2		Amended and Restated By-laws of CVS Caremark Corporation

This excerpt taken from the CVS 8-K filed Jan 3, 2008.

Item 9.01 Financial Statements and Exhibits.

(d)

Exhibits

99.1

Press Release, dated January 3, 2008, of CVS Caremark Corporation.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CVS CAREMARK

CORPORATION

By: /s/ David B. Rickard

David B. Rickard

Executive Vice President, Chief

Financial Officer and Chief

Administrative Officer

Dated: January 3, 2008

This excerpt taken from the CVS 8-K filed May 8, 2007.

Item 9.01 Financial Statements and Exhibits.

(d)

Exhibits

99.1

Press Release, dated May 8, 2007, of CVS/Caremark Corporation

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


						CVS/CAREMARK CORPORATION

						By:		/s/ David B. Rickard
								David B. Rickard Executive Vice President, Chief Financial Officer and Chief Administrative Officer Dated: May 8, 2007

This excerpt taken from the CVS 8-K filed Feb 26, 2007.

Item 9.01 Financial Statements and Exhibits

(d)		Exhibits

Exhibit No.		Document

Exhibit 99.1		Proxy statement supplement mailed by Caremark Rx, Inc. to its shareholders on February 24, 2007

Exhibit 99.2		Press Release, dated February 26, 2007, of CVS Corporation

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		CVS CORPORATION

Date:	February 26, 2007	By:	/s/ Douglas A. Sgarro

			Name:	Douglas A. Sgarro
			Title:	Executive Vice President and Chief
				Legal Officer

EXHIBIT INDEX

Exhibit No.		Document

Exhibit 99.1		Proxy statement supplement mailed by Caremark Rx, Inc. to its shareholders on February 24, 2007

Exhibit 99.2		Press Release, dated February 26, 2007, of CVS Corporation

This excerpt taken from the CVS 8-K filed Feb 13, 2007.

Item 9.01 Financial Statements and Exhibits

(d)		Exhibits

Exhibit No.		Document

99.1		Press Release, dated February 13, 2007, of CVS Corporation

99.2		Amendment to Waiver Agreement dated as of February 12, 2007 between CVS
		Corporation and Caremark Rx, Inc.

99.3		Opinion of Evercore Group, L.L.C.

99.4		Opinion of Lehman Brothers Inc.

99.5		Consent of Evercore Group, L.L.C.

99.6		Consent of Lehman Brothers Inc.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		CVS CORPORATION

Date:	February 13, 2007	By:	/s/ Douglas A. Sgarro

			Name:	Douglas A. Sgarro
			Title:	Executive Vice President and Chief
				Legal Officer

EXHIBIT INDEX

Exhibit No.		Document

99.1		Press Release, dated February 13, 2007, of CVS Corporation

99.2		Amendment to Waiver Agreement dated as of February 12, 2007 between CVS
		Corporation and Caremark Rx, Inc.

99.3		Opinion of Evercore Group, L.L.C.

99.4		Opinion of Lehman Brothers Inc.

99.5		Consent of Evercore Group, L.L.C.

99.6		Consent of Lehman Brothers Inc.

This excerpt taken from the CVS 8-K filed Feb 2, 2007.

Item 9.01 Financial Statements and Exhibits

(d)		Exhibits

Exhibit No.		Document

3.2		Amended and Restated By-laws of CVS Corporation

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		CVS CORPORATION


Date:	February 2, 2007	By:	/s/ Douglas A. Sgarro

			Name:	Douglas A. Sgarro
			Title:	Executive Vice President and Chief
				Legal Officer

EXHIBIT INDEX

Exhibit No.		Document

3.2		Amended and Restated By-laws of CVS Corporation

This excerpt taken from the CVS 8-K filed Feb 1, 2007.

Item 9.01 Financial Statements and Exhibits.

(d)

Exhibits

99.1

Press Release, dated February 1, 2007, of CVS Corporation

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


CVS CORPORATION

By:		/s/ David B. Rickard
		David B. Rickard
		Executive Vice President, Chief Financial Officer and Chief Administrative Officer

		Dated: February 1, 2007

This excerpt taken from the CVS 8-K filed Jan 19, 2007.

Item 9.01 Financial Statements and Exhibits

Exhibit No.		Document

Exhibit 8.1		Opinion of Davis Polk & Wardwell regarding material federal income tax consequences relating to the merger, as described in the Joint Proxy Statement/Prospectus included in Registration Statement (No. 333-139470) on Form S-4.

Exhibit 8.2		Opinion of King & Spalding LLP regarding material federal income tax consequences relating to the merger, as described in the Joint Proxy Statement/Prospectus included in Registration Statement (No. 333-139470) on Form S-4.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		CVS CORPORATION


Date:	January 19, 2007	By:	/s/ Douglas A. Sgarro

			Name:	Douglas A. Sgarro
			Title:	Executive Vice President and
				Chief Legal Officer

EXHIBIT INDEX

Exhibit No.		Document

Exhibit 8.1		Opinion of Davis Polk & Wardwell regarding material federal income tax consequences relating to the merger, as described in the Joint Proxy Statement/Prospectus included in Registration Statement (No. 333-139470) on Form S-4.

Exhibit 8.2		Opinion of King & Spalding LLP regarding material federal income tax consequences relating to the merger, as described in the Joint Proxy Statement/Prospectus included in Registration Statement (No. 333-139470) on Form S-4.

This excerpt taken from the CVS 8-K filed Jan 18, 2007.

Item 9.01 Financial Statements and Exhibits

Exhibit No.

99.1 Waiver Agreement dated as of January 16, 2007 between CVS Corporation and Caremark Rx, Inc. with respect to the Agreement and Plan of Merger dated as of November 1, 2006 among CVS Corporation, Caremark Rx, Inc. and Twain MergerSub Corp., as amended

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		CVS CORPORATION


Date:	January 18, 2007	By:	/s/ Douglas A. Sgarro

			Name:	Douglas A. Sgarro
			Title:	Executive Vice President
				and Chief Legal Officer

This excerpt taken from the CVS 8-K filed Dec 21, 2006.

Item 9.01 Financial Statements and Exhibits.

(d)

Exhibits



10.1		Employment Agreement dated as of September 1, 1999 between CVS and Mr. David B. Rickard.

10.2		Amendment dated as of December 19, 2006 to the Employment Agreement dated as of September 1, 1999 between CVS and Mr. David B. Rickard.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


CVS CORPORATION

By:		/S/ DAVID B. RICKARD
		David B. Rickard Executive Vice President, Chief Financial Officer and Chief Administrative Officer Dated: December 21, 2006

This excerpt taken from the CVS 8-K filed Nov 2, 2006.

Item 9.01 Financial Statements and Exhibits

Exhibit No.

2.1 Agreement and Plan of Merger dated as of November 1, 2006 among CVS, Caremark. and Merger Sub.

99.1 Press release dated November 1, 2006 relating to the proposed business combination of CVS and Caremark.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		CVS CORPORATION

Date:	November 2, 2006	By:	/s/ David B. Rickard

			Name:	David B. Rickard
			Title:	Executive Vice President, Chief
				Financial Officer and Chief
				Administrative Officer

This excerpt taken from the CVS DEFA14A filed Nov 2, 2006.

Item 9.01 Financial Statements and Exhibits

Exhibit No.

2.1 Agreement and Plan of Merger dated as of November 1, 2006 among CVS, Caremark. and Merger Sub.

99.1 Press release dated November 1, 2006 relating to the proposed business combination of CVS and Caremark.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		CVS CORPORATION

Date:	November 2, 2006	By:	/s/ David B. Rickard

			Name:	David B. Rickard
			Title:	Executive Vice President, Chief
				Financial Officer and Chief
				Administrative Officer

This excerpt taken from the CVS 8-K filed Nov 1, 2006.

Item 9.01 Financial Statements and Exhibits.

(d)

Exhibits

99.1

Press Release, dated November 1, 2006, of CVS Corporation

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


CVS CORPORATION

By:		/s/ David B. Rickard
		David B. Rickard Executive Vice President, Chief Financial Officer and Chief Administrative Officer

		Dated: November 1, 2006

This excerpt taken from the CVS 8-K filed Oct 10, 2006.

Item 9.01 Financial Statements and Exhibits.

(d)

Exhibits

99.1

Press Release, dated October 10, 2006 of CVS Corporation

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


CVS CORPORATION

By:		/S/ DAVID B. RICKARD
		David B. Rickard Executive Vice President, Chief Financial Officer and Chief Administrative Officer Dated: October 10, 2006

This excerpt taken from the CVS 8-K filed Aug 15, 2006.

Item 9.01. Financial Statements and Exhibits.

(d)	Exhibits

1.1		Underwriting Agreement dated August 10, 2006 among CVS Corporation and Lehman Brothers Inc., Banc of America Securities LLC, BNY Capital Markets, Inc. and Wachovia Capital Markets, LLC, as representatives of the Underwriters.

4.1		Senior Indenture dated August 15, 2006 between CVS Corporation, as issuer, and The Bank of New York Trust Company, N.A., as trustee, including form of debt security.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		CVS CORPORATION

Date:	August 15, 2006	By:	/s/ David B. Rickard

		Name:	David B. Rickard
		Title:	Executive Vice President, Chief Financial
			Officer and Chief Administrative Officer

This excerpt taken from the CVS 8-K filed Aug 3, 2006.

Item 9.01 Financial Statements and Exhibits.

(d)

Exhibits

99.1

Press Release, dated August 3, 2006, of CVS Corporation

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


CVS CORPORATION

By:		/s/ David B. Rickard
		David B. Rickard Executive Vice President, Chief Financial Officer and Chief Administrative Officer

		Dated: August 3, 2006

This excerpt taken from the CVS 8-K filed Jun 30, 2006.

Item 9.01 Financial Statements and Exhibits


Exhibit 99.1		Carve Out Special Purpose Financial Statements of the Albertson’s, Inc. Standalone Drug Business (an integrated operation within Albertson’s, Inc.) as of February 2, 2006, May 4, 2006 and May 5, 2005.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	CVS CORPORATION

Date: June 30, 2006	By:	/s/ David B. Rickard
	Name:	David B. Rickard
	Title:	Executive Vice President, Chief Financial Officer and Chief Administrative Officer

This excerpt taken from the CVS 8-K filed Jun 2, 2006.

Item 9.01 Financial Statements and Exhibits.

The Company has not included in this Current Report on Form 8-K the financial statements of the acquired business and pro forma financial information provided for in Item 9.01 of Form 8-K. If required, the Company will file such financial statements and pro forma information as an amendment to this Form 8-K no later than 75 days following June 2, 2006.

(d)

Exhibits

10.1

Asset Purchase Agreement dated as of January 22, 2006 among CVS, CVS Pharmacy, Albertson’s, SUPERVALU, INC., New Aloha Corporation, and the Sellers listed on Annex A thereto (incorporated by reference to Exhibit 10.1 to CVS Corporation’s Current Report on Form 8-K dated January 22, 2006).

10.2

Amendment dated as of June 2, 2006 to the Asset Purchase Agreement dated as of January 22, 2006 among CVS, CVS Pharmacy, Albertson’s, SUPERVALU, INC., New Aloha Corporation, and the Sellers listed on Annex A thereto.

10.3

364-day Credit Agreement dated as of May 12, 2006 by and among the Registrant, the lenders party thereto, Bank of America, N.A. and Wachovia Bank, National Association, as Co-Syndication Agents, and The Bank of New York, as Administrative Agent.

10.4

Five Year Credit Agreement dated as of May 12, 2006 by and among the Registrant, the lenders party thereto, Bank of America, N.A., Lehman Brothers Inc. and Wachovia Bank, National Association, as Co-Syndication Agents, Keybank National Association, as Documentation Agent, and The Bank of New York, as Administrative Agent.

10.5

Bridge Credit Agreement dated as of May 24, 2006 by and among the Registrant, the lenders party thereto and Lehman Commercial Paper Inc., as Administrative Agent.

99.1

Press Release Dated June 2, 2006 of CVS Corporation.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CVS CORPORATION

By: /s/ David B. Rickard

David B. Rickard

Executive Vice President,

Chief Financial Officer and

Chief Administrative Officer

Dated: June 2, 2006

This excerpt taken from the CVS 8-K filed May 4, 2006.

Item 9.01 Financial Statements and Exhibits.

(d)

Exhibits

99.1

Press Release, dated May 4, 2006, of CVS Corporation

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


CVS CORPORATION

By:		/s/ David B. Rickard
		David B. Rickard
		Executive Vice President, Chief Financial Officer and Chief Administrative Officer

		Dated: May 4, 2006

This excerpt taken from the CVS 8-K filed Jan 23, 2006.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.


Exhibit No.		Description
10.1		Asset Purchase Agreement dated as of January 22, 2006 among CVS, CVS Pharmacy, Albertson’s, SUPERVALU, New Aloha Corporation and the sellers listed on Annex A thereto.

99.1		Press Release, dated January 23, 2006.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


CVS CORPORATION

By:		/S/ DAVID B. RICKARD
		David B. Rickard Executive Vice President, Chief Financial Officer and Chief Administrative Officer Dated: January 23, 2006

This excerpt taken from the CVS 8-K filed Dec 23, 2005.

Item 9.01. Financial Statements and Exhibits.

(d)

Exhibits.


Exhibit No.		Description

99.1		Press Release, dated December 22, 2005.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CVS CORPORATION

By: /s/ David B. Rickard

David B. Rickard

Executive Vice President, Chief Financial

Officer and Chief Administrative Officer

Dated: December 22, 2005

This excerpt taken from the CVS 8-K filed Oct 6, 2005.

Item 9.01 Financial Statements and Exhibits.

(c)

Exhibits

99.1

Press Release, dated October 6, 2005 of CVS Corporation

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


CVS CORPORATION

By:		/s/ David B. Rickard
		David B. Rickard Executive Vice President, Chief Financial Officer and Chief Administrative Officer

		Dated: October 6, 2005

CVS Caremark Corporation (CVS)

CVS » Topics » Item 9.01 Financial Statements and Exhibits.

EXCERPTS ON THIS PAGE:

RELATED TOPICS for CVS:

"Item 9.01 Financial Statements and Exhibits." elsewhere: